A new, innovative, chromogenic ISH technology: reducing protocol length from two days to approximately 2.5 hours. In a simplified protocol we have removed the need for RNase free solutions & labware, the overnight hybridization and harsh stringent wash conditions. The proprietary DNA probe technology ensures high specificity and accuracy for the target. The result is […]
The 5′ and 3′ ends of DNA are fundamental to its structure and function, particularly in the process of DNA replication. These structural ends are also significant in a variety of molecular biology techniques, including Fluorescence in Situ Hybridization (FISH), a clinical testing method used to detect and study genetic abnormalities.
November 30, 2023* – Biocare Medical, a leader in immunohistochemistry (IHC) and in situ hybridization (ISH) diagnostics, is proud to introduce the intelliPATH+ Advanced Staining Instrument. This state-of-the-art upgrade solidifies Biocare Medical’s dedication to superior automated IHC staining processes and marks a significant expansion of its advanced, automated staining portfolio, which includes the acclaimed ONCORE […]
Mesothelioma is a rare but aggressive cancer affecting the mesothelial lining of the lungs, abdomen, reproductive system, or heart. It is often challenging to diagnose due to its similarities to other conditions. Immunohistochemistry (IHC) staining can play a crucial role in the accurate diagnosis and subtyping of mesothelioma.
November 6, 2023 – Biocare Medical, a trusted provider of immunohistochemistry (IHC) instrumentation, antibodies and molecular probes for tumor diagnostics, is proud to announce a strategic partnership with DC3 Therapeutics as their preferred vendor. DC3 Therapeutics is a world-class full-service Contract Research Organization (CRO) with extensive experience in drug development and the pharmaceutical industry. The […]
Centromeres and telomeres are essential components of chromosomes, playing distinct roles in their structure and function. In the context of Fluorescence In Situ Hybridization (FISH), a molecular biology technique used for visualizing specific DNA sequences within chromosomes, labeling centromeres and telomeres can provide valuable information about chromosome organization, integrity, and genetic abnormalities.
Oncoviruses are a group of viruses that have the ability to cause cancer or contribute to the development of cancer. These viruses are capable of integrating their genetic material into the DNA of the host cell, leading to disruptions in normal cellular processes, uncontrolled cell division, and, ultimately, the formation of tumors. While not all […]
October 31, 2023 – Biocare Medical, a leading provider in the immunohistochemistry sector, introduces their newest innovation: ARC (Antigen Retrieval Chamber). The addition of ARC to their automation portfolio advances Biocare Medical’s suite of decloaking systems built for consistent, reliable heat-induced epitope retrieval. Tailored for Heat-Induced Epitope Retrieval (HIER) with in vitro diagnostic (IVD) labeling, […]
San Francisco, October 31, 2023 – Ikonisys SA a company specializing in the early and accurate detection of cancer with a unique fully-automated solution for medical diagnostic labs, has partnered with Biocare Medical, a leader in immunohistochemistry (IHC) and FISH (Fluorescent in situ hybridization) tools and reagents. This alliance focuses on expanding the global distribution […]
Mammary Paget’s Disease (MPD) is a rare and often misdiagnosed type of breast cancer that primarily affects the nipple and areola complex.2,7 It occurs in approximately 1- 4% of all breast cancer cases and typically presents with eczema-like changes, such as redness, itching, and scaling of the nipple and areola.2,7 Most patients with MPD have […]